Business ❯Finance ❯Investments ❯Stock Market

Pharmaceuticals

Novo Nordisk Faces Investor Concerns as Wegovy Sales Stagnate and Competition Intensifies

Pfizer Faces Activist Pressure as Ex-Execs Withdraw Support for Starboard